Early study finds new lymphoma drug effective: Eighty percent of patients with a subset of lymphoma…
In early research led by the University of Michigan Health Rogel Cancer Center, the oral medication zanubrutinib was found to help most patients with a slow-growing type of cancer known as marginal zone lymphoma.
Cancers shrunk in 80% of…